Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1060850

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary State for Health and Social Care, what assessment he has made of the effect of toxic air on children’s health.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	220891
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Poor air quality is the largest environmental risk to public health in the United Kingdom. Long-term exposure to air pollution can cause chronic conditions such as cardiovascular, respiratory diseases and cancer, leading to reduced life expectancy.</p><p> </p><p>Air pollution has a particular impact on children as they grow. There is evidence that the process of normal lung function growth in children is suppressed by long-term exposure to air pollution.</p><p> </p><p>The effects of air pollution on children’s health are being studied in research projects. The EXHALE Programme is a London study on air pollution and children’s lung health. The Committee on the Medical Effects of Air Pollutants has started work to consider the evidence for the effects of air pollution on adverse birth outcomes. The Royal College of Paediatrics and Child Health is working on a report on ‘Indoor Air Quality on Children and Young People’s Health across the Life Course’.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:13:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

997392

	registered interest
	date	29/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Public Health England: Staff
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many staff (a) are employed directly by, (b) are seconded to and (c) work under contract in Public Health England.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	185151
	answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>The number of staff within Public Health England (PHE), reported as both number of separate individual persons (headcount) and Whole Time Equivalents (WTE) as at 30 September 2018 are available in the following table.</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Headcount</p></td><td><p>WTE</p></td></tr><tr><td><p>Employed directly by PHE</p></td><td><p>5,395</p></td><td><p>5,004</p></td></tr><tr><td><p>Seconded to PHE</p></td><td><p>30</p></td><td><p>11.73</p></td></tr><tr><td><p>Work under contract in PHE*</p></td><td><p>63</p></td><td><p>61.8</p></td></tr></tbody></table><p> </p><p>Notes:</p><p>*‘PHE has interpreted “work under contract” as “contingent labour”.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:22:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4523 label Biography information for Catherine West

1054660

	registered interest
	date	04/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cerliponase Alfa
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will hold meetings with families of children with ceroid lipofuscinosis type 2 disease on the availability of Brineura on the NHS.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	216384
	answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>The Department has no plans currently. The National Institute for Health and Care Excellence is currently developing guidance on Brineura (Cerliponase alfa) for treating neuronal ceroid lipofuscinosis type 2 under the highly specialised technology programme. Further information can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/indevelopment/gid-hst10008" target="_blank">https://www.nice.org.uk/guidance/indevelopment/gid-hst10008</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/02/2019 15:49:07 answering member 4067 label Biography information for Steve Brine
	tabling member	4658 label Biography information for Alex Sobel

1050056

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 15 October 2018 to Question 174612, Air Pollution, as the COMEAP study to which he refers was carried out in 2012, if he will (a) ask that body to conduct a further study on the effects of particulate air pollution on mortality in the UK and (b) will ensure that such a new study includes PM0.1 and PM1.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	213200
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom, based on studies reporting associations of mortality risk with fine particulate matter (PM2.5), which includes PM1 and PM0.1, and nitrogen dioxide (NO<sub>2</sub>). No separate assessments of the impact of the PM1 and PM0.1 components (particulate matter with an aerodynamic diameter smaller than 1 or 0.1 microns respectively) of particulate air pollution have been produced. The recent Committee on the Medical Effects of Air Pollutants assessment is available to view at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality" target="_blank">https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality</a></p><p> </p><p>The reviews by the Health Effects Institute and World Health Organization of the effects of different components of air pollution, including ultrafine particles (PM0.1), concluded that there is currently limited evidence on the effects on health of ultrafine particles. These reviews are available at the following links:</p><p> </p><p><a href="https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles" target="_blank">https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles</a></p><p> </p><p><a href="http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1" target="_blank">http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1</a></p><p> </p><p>Currently, Public Health England has no plans to engage in work on the effects of PM1 and PM0.1 particles on human health.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:19:38 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1010226

	registered interest
	date	19/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Incinerators: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent research he has (a) commissioned and (b) considered of the effects on human health of municipal waste incinerators on people living within (i) 0.5 kilometre, (ii) 0.9 kilometre, (iii) 1 kilometre, (iv) 2 kilometres and (v) 5 kilometres of those incinerators.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	192711
	answer	answer is ministerial correction date of answer 27/11/2018 answer text <p>Public Health England (PHE) funded the Small Area Health Statistics Unit, and King’s College London, to carry out a study to further extend the evidence base as to whether emissions from modern municipal waste incinerators affect human health.</p><p> </p><p>The first of a series of papers from this study was published on 22 November 2018. The paper ‘Fetal growth, stillbirth, infant mortality and other birth outcomes near UK municipal waste incinerators; retrospective population based cohort and case-control study’ is available to view at the following link:</p><p> </p><p><a href="https://www.sciencedirect.com/science/article/pii/S0160412018316398" target="_blank">https://www.sciencedirect.com/science/article/pii/S0160412018316398</a></p><p> </p><p>The paper found no evidence of a link between exposure to particulate matter emitted from modern municipal waste incinerators as modelled from emissions data, or living close to modern municipal waste incinerators, and infant mortality, low birth weight, still birth or the other birth outcomes investigated.</p><p> </p><p>PHE’s position is that well run and regulated modern municipal waste incinerators are not a significant risk to public health. PHE will review its advice in light of new substantial research on the health effects of incinerators published in peer reviewed journals. To date, PHE is not aware of any evidence that requires a change in their position statement.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192712 question first answered 27/11/2018 17:09:00 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1007006

	registered interest
	date	14/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ovarian Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to improve early diagnosis of ovarian cancer.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	191308
	answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ (BCOC) campaigns to help improve early detection of cancer. In 2014 PHE ran a regional ovarian cancer campaign in the North West of England, and in 2017 a pilot which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer was carried out in the East and West Midlands. PHE is currently undertaking new data analysis and research to determine the future direction of BCOC activity in 2019/20 and will take into consideration the outcomes of these previous campaigns. PHE will also consult with NHS England on the timings and location of any future campaigns.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 11:44:06 answering member 4067 label Biography information for Steve Brine
	tabling member	478 label Biography information for Lord Field of Birkenhead

1006075

	registered interest
	date	13/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether a non-disclosure agreement was made between Public Health England and the National Guideline Centre in relation to the review of literature on prescribed medicines.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	190914
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>‘Prescribed Medicines: An Evidence Review’ is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.</p><p> </p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients’ experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.</p><p> </p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.</p><p> </p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190913 question first answered 20/11/2018 15:07:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4436 label Biography information for Cat Smith

1051475

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, by what date the proposed doubling of places on its PrEP Impact Trial will be achieved.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	214543
	answer	answer is ministerial correction date of answer 04/02/2019 answer text <p>On 30 January, the Secretary of State for Health and Social Care announced that the Pre-exposure Prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Work is underway with partners to take this forward. The PrEP Oversight Board has requested information on local capacity to make the additional places available, and will review this later in February. The Secretary of State also announced the Government’s commitment to ending new HIV transmissions in England by 2030. To support this work, an expert group will be established to develop an action plan over the course of this year. The important role of PrEP, as part of combination HIV prevention efforts, will be considered as part of this process.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 214541 214542 question first answered 04/02/2019 18:09:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4036 label Biography information for Luciana Berger

1063647

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	GP at Hand: Birmingham
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason NHS England lifted the ban on the Babylon GP at Hand plans to expand into Birmingham before the independent evaluation by IPOS Mori of that service is published next month.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	222634
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS England has considered the expansion of the service to Birmingham following initial concerns, in particular regarding access to immunisation and screening programmes for Babylon GP at Hand patients, and a solution has been identified. NHS England will now work together with NHS Hammersmith and Fulham and Birmingham and Solihull Clinical Commissioning Groups (CCGs), national screening services, and Babylon GP at Hand to mobilise the service and agree a start date.</p><p>General practice payments are made to practices according to their registered patient list size, so the funding for general practice care will follow the patients. NHS England will shortly engage on changes to out of area registration rules, some of the current payments to primary care providers and the mechanisms by which new providers can enter the market.</p><p>The new General Practitioner Contract Framework made two changes to the current payment system:</p><p>- the rurality index payment will be amended to apply to patients living within a practice catchment area only, rather than to all patients. This is to better reflect costs; and</p><p>- the London adjustment will be amended to apply to patients resident in London, rather than registered with a London-based practice</p><p> </p><p>CCG allocations have been revised for 2019/20. Hammersmith and Fulham CCG’s allocation takes account of the increased list size of the GP at Hand practice, with the CCG’s funding growth determined by an assessment of the CCG’s fair share of overall funding and rules on the pace of change in funding allocations.</p><p> </p><p>All patients registered with the Babylon GP at Hand practice are recorded as patients of Hammersmith and Fulham CCG.</p><p> </p><p>Hammersmith and Fulham CCG have commissioned an independent evaluation of the Babylon GP at Hand practice. This will look at the impact of the service on patient experience, primary care workforce, use of other services, such as accident and emergency departments and walk-in centres, and system value.</p><p> </p><p>Babylon GP at Hand will provide physical premises in both London and Birmingham for those patients who require a face-to-face consultation. Under the current GP of Choice Policy, the CCGs where ‘out of area’ patients live are required to ensure out of hours care and home visits can be accessed by those patients in their resident area if they need it.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222635 222637 222638 222639 222640 question first answered 21/02/2019 16:24:56 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

995576

	registered interest
	date	26/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: South Shields
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason the flu vaccine is not available for all people over 65 in the South Shields Constituency; and when he plans to make that vaccine available for everyone in that age group.
	tabling member constituency	South Shields
	tabling member printed	Mrs Emma Lewell-Buck
	uin	184427
	answer	answer is ministerial correction date of answer 31/10/2018 answer text <p>The adjuvanted trivalent flu (aTIV) is available to everyone over 65 years of age.</p><p> </p><p>To enable adequate supply of the aTIV to be available in 2018-19, deliveries have had to be phased across three months; 40% in September, 20% in October and 40% in November. All general practice and pharmacies in the United Kingdom will have the delivery of their orders by 17 November. This is a specific arrangement for 2018-19 to allow effective supply of the vaccine.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/10/2018 14:13:19 answering member 4067 label Biography information for Steve Brine
	tabling member	4277 label Biography information for Mrs Emma Lewell-Buck